Jing Xue

Jing Xue

Auto-generated profile, based on publicly available information

Jing Xue

Department of Pathology, The First Affiliated Hospital of Xinjiang Medical University, No. 137 Liyushan Southern Road, Urumqi, The Xinjiang Uygur Autonomous Region of China, 830054, PR China; Xinjiang Medical University, No. 393 Xinyi Road, Urumqi, The Xinjiang Uygur Autonomous Region of China, 830011, PR China

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 October 2019 in Oncology Letters
Verified
Journal Article
Open access
PDF file
JXJing Xue
Jing Xue
HGHai‑Xia Gao
Hai‑Xia Gao
WSWei Sang
Wei Sang
WCWen‑Li Cui
Wen‑Li Cui
MLMing Liu
Ming Liu
WZWei Zhang
Wei Zhang
Differentially methylated genes (DMGs) serve a crucial role in the pathogenesis of glioma via the regulation of the cell cycle, proliferation, apoptosis, migration, infiltration, DNA repair and signaling pathways. This study aimed to identify aberrant DMGs and pathways by comprehensive bioinformatics analysis. The gene expression profile of GSE28094 was downloaded from the Gene Expression Omnibus (GEO) database, and the GEO2R online tool was used to find DMGs. Gene Ontology (GO) functional analysis and Kyoto Encyclopedia of Genes and Genomes pathway enrichment analysis of the DMGs were performed by using the Database for Annotation Visualization and Integrated Discovery. A protein-protein interaction (PPI) network was constructed with Search Tool for the Retrieval of Interacting Genes. Analysis of modules in the PPI networks was performed by Molecular Complex Detection in Cytoscape software, and four modules were performed. The hub genes with a high degree of connectivity were verified by The Cancer Genome Atlas database. A total of 349 DMGs, including 167 hypermethylation genes, were enriched in biological processes of negative and positive regulation of cell proliferation and positive regulation of transcription from RNA polymerase II promoter. Pathway analysis enrichment revealed that cancer regulated the pluripotency of stem cells and the PI3K-AKT signaling pathway, whereas 182 hypomethylated genes were enriched in biological processes of immune response, cellular response to lipopolysaccharide and peptidyl-tyrosine phosphorylation. Pathway enrichment analysis revealed cytokine-cytokine receptor interaction, type I diabetes mellitus and TNF signaling pathway. A total of 20 hub genes were identified, of which eight genes were associated with survival, including notch receptor 1 (NOTCH1), SRC proto-oncogene (also known as non-receptor tyrosine kinase, SRC), interleukin 6 (IL6), matrix metallopeptidase 9 (MMP9), interleukin 10 (IL10), caspase 3 (CASP3), erb-b2 receptor tyrosine kinase 2 (ERBB2) and epidermal growth factor (EGF). Therefore, bioinformatics analysis identified a series of core DMGs and pathways in glioma. The results of the present study may facilitate the assessment of the tumorigenicity and progression of glioma. Furthermore, the significant DMGs may provide potential methylation-based biomarkers for the precise diagnosis and targeted treatment of glioma.

1 November 2020 in Pathology - Research and Practice
Verified
Journal Article
Closed access
JXJing Xue
Jing Xue
WSWei Sang
Wei Sang
LSLi-Ping Su
Li-Ping Su
HGHai-Xia Gao
Hai-Xia Gao
WCWen-Li Cui
Wen-Li Cui
WZWei Zhang
Wei Zhang

1 September 2019 in Pathology - Research and Practice
Verified
Journal Article
Closed access
HGHai-Xia Gao
Hai-Xia Gao
ANAijiang Nuerlan
Aijiang Nuerlan
GAGulinaer Abulajiang
Gulinaer Abulajiang
WCWen-Li Cui
Wen-Li Cui
JXJing Xue
Jing Xue
XLXinxia Li
Xinxia Li

1 February 2020 in Pathology - Research and Practice
Verified
Journal Article
Closed access
HGHai-Xia Gao
Hai-Xia Gao
SLSi-Jing Li
Si-Jing Li
JNJing Niu
Jing Niu
ZMZhi-Ping Ma
Zhi-Ping Ma
ANAijiang Nuerlan
Aijiang Nuerlan
XLXinxia Li
Xinxia Li